ACS Medicinal Chemistry Letters
Letter
Lin, C. W.; Ogiela, C. A.; Collins, C. A.; Brune, M. E.; Bush, E. N.;
Droz, B. A.; Fey, T. A.; Knourek-Segel, V. E.; Shapiro, R.; Jacobson, P.
B.; Beno, D. W. A.; Turner, T. M.; Sham, H. L.; Liu, G. Discovery and
Pharmacological Evaluation of Growth Hormone Secretagogue
Receptor Antagonists. J. Med. Chem. 2006, 49, 4459−4469.
(11) Zhao, H.; Xin, Z.; Liu, G.; Schaefer, V. G.; Falls, H. D.;
Kaszubska, W.; Collins, C. A.; Sham, H. L. Discovery of Tetralin
Carboxamide Growth Hormone Secretagogue Receptor Antagonists
via Scaffold Manipulation. J. Med. Chem. 2004, 47, 6655−6657.
(12) Demange, L.; Boeglin, D.; Moulin, A.; Mousseaux, D.; Ryan, J.;
Wang, G.; Xiao, J.; Zhang, Y. Discovery of PF-5190457, a Potent,
Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist
Clinical Candidate. ACS Med. Chem. Lett. 2014, 5, 474−479.
(22) Els, S.; Beck-Sickinger, A. G.; Chollet, C. Ghrelin Receptor:
High Constitutive Activity and Methods for Developing Inverse
Agonists. Methods Enzymol 2010, 485, 103−121.
(23) Edwards, M. P.; Price, D. A. Role of Physicochemical Properties
and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks. In
Annual Reports in Medicinal Chemistry; John, E. M., Ed.; Academic
Press: New York, 2010; Vol. 45, Chapter 23, pp 380−391.
(24) Leeson, P. D.; Springthorpe, B. The Influence of Drug-Like
Concepts on Decision-Making in Medicinal Chemistry. Nat. Rev. Drug
Discovery 2007, 6, 881−890.
(25) Feng, B.; Mills, J. B.; Davidson, R. E.; Mireles, R. J.; Janiszewski,
J. S.; Troutman, M. D.; de Morais, S. M. In Vitro P-glycoprotein
Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs
in the Central Nervous System. Drug Metab. Dispos. 2008, 36, 268−
275.
(26) Wager, T. T.; Chandrasekaran, R. Y.; Hou, X.; Troutman, M.
D.; Verhoest, P. R.; Villalobos, A.; Will, Y. Defining Desirable Central
Nervous System Drug Space through the Alignment of Molecular
Properties, in Vitro ADME, and Safety Attributes. ACS Chem. Neurosci.
2010, 1, 420−434.
(27) Hitchcock, S. A. Structural Modifications that Alter the P-
Glycoprotein Efflux Properties of Compounds. J. Med. Chem. 2012, 55,
4877−4895.
(28) Hartz, R. A.; Ahuja, V. T.; Zhuo, X.; Mattson, R. J.; Denhart, D.
J.; Deskus, J. A.; Vrudhula, V. M.; Pan, S.; Ditta, J. L.; Shu, Y.-Z.;
Grace, J. E.; Lentz, K. A.; Lelas, S.; Li, Y.-W.; Molski, T. F.;
Krishnananthan, S.; Wong, H.; Qian-Cutrone, J.; Schartman, R.;
Denton, R.; Lodge, N. J.; Zaczek, R.; Macor, J. E.; Bronson, J. J. A
Strategy to Minimize Reactive Metabolite Formation: Discovery of
(S)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-di-
methylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as
a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1
Receptor Antagonist. J. Med. Chem. 2009, 52, 7653−7668.
(29) Orr, S. T. M.; Cabral, S.; Fernando, D. P.; Makowski, T. One-
Pot Synthesis of Chiral Azetidines from Chloroaldehyde and Chiral
Amines. Tetrahedron Lett. 2011, 52, 3618−3620.
(30) Fernando, D. P.; Jiao, W.; Polivkova, J.; Xiao, J.; Coffey, S. B.;
Rose, C.; Londregan, A.; Saenz, J.; Beveridge, R.; Zhang, Y.; Storer, G.
E.; Vrieze, D.; Erasga, N.; Jones, R.; Khot, V.; Cameron, K. O.;
McClure, K. F.; Bhattacharya, S. K.; Orr, S. T. M. Spiroazetidine−
Piperidine Bromoindane as a Key Modular Template to Access a
Variety of Compounds via C−C and C−N Bond-Forming Reactions.
Tetrahedron Lett. 2012, 53, 6351−6354.
(31) Cobley, C. J.; van den Heuvel, M.; Abbadi, A.; de Vries, J. G.
Platinum Catalysed Hydrolytic Amidation of Unactivated Nitriles.
Tetrahedron Lett. 2000, 41, 2467−2470.
́
Berge, G.; Gagne, D.; Heitz, A.; Perrissoud, D.; Locatelli, V.; Torsello,
A.; Galleyrand, J.-C.; Fehrentz, J.-A.; Martinez, J. Synthesis and
Pharmacological in Vitro and in Vivo Evaluations of Novel Triazole
Derivatives as Ligands of the Ghrelin Receptor. 1. J. Med. Chem. 2007,
50, 1939−1957.
́
(13) Moulin, A.; Demange, L.; Berge, G.; Gagne, D.; Ryan, J.;
Mousseaux, D.; Heitz, A.; Perrissoud, D.; Locatelli, V.; Torsello, A.;
Galleyrand, J.-C.; Fehrentz, J.-A.; Martinez, J. Toward Potent Ghrelin
Receptor Ligands Based on Trisubstituted 1,2,4-Triazole Structure. 2.
Synthesis and Pharmacological in Vitro and in Vivo Evaluations. J.
Med. Chem. 2007, 50, 5790−5806.
(14) Moulin, A.; Demange, L.; Ryan, J.; Mousseaux, D.; Sanchez, P.;
Berge, G.; Gagne, D.; Perrissoud, D.; Locatelli, V.; Torsello, A.;
́
Galleyrand, J.-C.; Fehrentz, J.-A.; Martinez, J. New Trisubstituted
1,2,4-Triazole Derivatives as Potent Ghrelin Receptor Antagonists. 3.
Synthesis and Pharmacological in Vitro and in Vivo Evaluations. J.
Med. Chem. 2008, 51, 689−693.
(15) Pasternak, A.; Goble, S. D.; deJesus, R. K.; Hreniuk, D. L.;
Chung, C. C.; Tota, M. R.; Mazur, P.; Feighner, S. D.; Howard, A. D.;
Mills, S. G.; Yang, L. Discovery and Optimization of Novel 4-
[(Aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]-
benzenesulfonamide Ghrelin Receptor Antagonists. Bioorg. Med. Chem.
Lett. 2009, 19, 6237−6240.
(16) Mihalic, J. T.; Kim, Y.-J.; Lizarzaburu, M.; Chen, X.; Deignan, J.;
Wanska, M.; Yu, M.; Fu, J.; Chen, X.; Zhang, A.; Connors, R.; Liang,
L.; Lindstrom, M.; Ma, J.; Tang, L.; Dai, K.; Li, L. Discovery of a New
Class of Ghrelin Receptor Antagonists. Bioorg. Med. Chem. Lett. 2012,
22, 2046−2051.
(17) Yu, M.; Lizarzaburu, M.; Beckmann, H.; Connors, R.; Dai, K.;
Haller, K.; Li, C.; Liang, L.; Lindstrom, M.; Ma, J.; Motani, A.; Wanska,
M.; Zhang, A.; Li, L.; Medina, J. C. Identification of Piperazine-
Bisamide GHSR Antagonists for the Treatment of Obesity. Bioorg.
Med. Chem. Lett. 2010, 20, 1758−1762.
(18) Hanrahan, P.; Bell, J.; Bottomley, G.; Bradley, S.; Clarke, P.;
Curtis, E.; Davis, S.; Dawson, G.; Horswill, J.; Keily, J.; Moore, G.;
Rasamison, C.; Bloxham, J. Substituted Azaquinazolinones as
Modulators of GHSr-1a for the Treatment of Type II Diabetes and
Obesity. Bioorg. Med. Chem. Lett. 2012, 22, 2271−2278.
(19) Kung, D. W.; Coffey, S. B.; Jones, R. M.; Cabral, S.; Jiao, W.;
Fichtner, M.; Carpino, P. A.; Rose, C. R.; Hank, R. F.; Lopaze, M. G.;
Swartz, R.; Chen, H.; Hendsch, Z.; Posner, B.; Wielis, C. F.; Manning,
B.; Dubins, J.; Stock, I. A.; Varma, S.; Campbell, M.; DeBartola, D.;
Kosa-Maines, R.; Steyn, S. J.; McClure, K. F. Identification of
Spirocyclic Piperidine-Azetidine Inverse Agonists of the Ghrelin
Receptor. Bioorg. Med. Chem. Lett. 2012, 22, 4281−4287.
(20) McClure, K. F.; Jackson, M.; Cameron, K. O.; Kung, D. W.;
Perry, D. A.; Orr, S. T. M.; Zhang, Y.; Kohrt, J.; Tu, M.; Gao, H.;
Fernando, D.; Jones, R.; Erasga, N.; Wang, G.; Polivkova, J.; Jiao, W.;
Swartz, R.; Ueno, H.; Bhattacharya, S. K.; Stock, I. A.; Varma, S.;
Bagdasarian, V.; Perez, S.; Kelly-Sullivan, D.; Wang, R.; Kong, J.;
Cornelius, P.; Michael, L.; Lee, E.; Janssen, A.; Steyn, S. J.; Lapham, K.;
Goosen, T. Identification of Potent, Selective, CNS-Targeted Inverse
Agonists of the Ghrelin Receptor. Bioorg. Med. Chem. Lett. 2013, 23,
5410−5414.
(32) Balicki, R.; Kaczmarek, Ł. Mild and Efficient Conversion of
Nitriles to Amides with Basic Urea-Hydrogen Peroxide Adduct. Synth.
Commun. 1993, 23, 3149−3155.
(33) Garrett, C. E.; Jiang, X.; Prasad, K.; Repic, O. New Observations
̌
on Peptide Bond Formation Using CDMT. Tetrahedron Lett. 2002, 43,
4161−4165.
(34) Di, L.; Whitney-Pickett, C.; Umland, J. P.; Zhang, H.; Zhang, X.;
Gebhard, D. F.; Lai, Y.; Federico, J. J.; Davidson, R. E.; Smith, R.;
Reyner, E. L.; Lee, C.; Feng, B.; Rotter, C.; Varma, M. V.; Kempshall,
S.; Fenner, K.; El-kattan, A. F.; Liston, T. E.; Troutman, M. D.
Development of a New Permeability Assay Using Low-Efflux MDCKII
Cells. J. Pharm. Sci. 2011, 100, 4974−4985.
(35) Boxenbaum, H. Pharmacokinetic Tricks and Traps: Flip-Flop
Models. J. Pharm. Pharm. Sci. 1998, 1, 90−91.
(36) Orr, S. T. M.; Ripp, S. L.; Ballard, T. E.; Henderson, J. L.; Scott,
D. O.; Obach, R. S.; Sun, H.; Kalgutkar, A. S. Mechanism-Based
Inactivation (MBI) of Cytochrome P450 Enzymes: Structure−Activity
Relationships and Discovery Strategies To Mitigate Drug−Drug
Interaction Risks. J. Med. Chem. 2012, 55, 4896−4933.
(21) Bhattacharya, S. K.; Andrews, K.; Beveridge, R.; Cameron, K.
O.; Chen, C.; Dunn, M.; Fernando, D.; Gao, H.; Hepworth, D.;
Jackson, V. M.; Khot, V.; Kong, J.; Kosa, R. E.; Lapham, K.; Loria, P.
M.; Londregan, A. T.; McClure, K. F.; Orr, S. T. M.; Patel, J.; Rose, C.;
Saenz, J.; Stock, I. A.; Storer, G.; VanVolkenburg, M.; Vrieze, D.;
F
dx.doi.org/10.1021/ml500414n | ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX